Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Teva
Harvard Business School
Dow
Fish and Richardson
Cipla
Queensland Health
Cantor Fitzgerald
QuintilesIMS
Johnson and Johnson

Generated: October 23, 2017

DrugPatentWatch Database Preview

Cipher Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for CIPHER PHARMS INC, and what generic alternatives to CIPHER PHARMS INC drugs are available?

CIPHER PHARMS INC has two approved drugs.

There is one US patent protecting CIPHER PHARMS INC drugs.

There are three patent family members on CIPHER PHARMS INC drugs in three countries and two supplementary protection certificates in two countries.

Summary for Applicant: Cipher Pharms Inc

International Patents:3
US Patents:1
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipher Pharms Inc
CONZIP
tramadol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022370-003May 7, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
Cipher Pharms Inc
LIPOFEN
fenofibrate
CAPSULE;ORAL021612-003Jan 11, 2006RXYesYes► Subscribe► Subscribe► Subscribe
Cipher Pharms Inc
CONZIP
tramadol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022370-004Aug 1, 2011RXYesNo► Subscribe► Subscribe► Subscribe
Cipher Pharms Inc
CONZIP
tramadol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022370-001May 7, 2010RXYesYes► Subscribe► SubscribeY ► Subscribe
Cipher Pharms Inc
LIPOFEN
fenofibrate
CAPSULE;ORAL021612-002Jan 11, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Cipher Pharms Inc
CONZIP
tramadol hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022370-002May 7, 2010RXYesNo► Subscribe► SubscribeY ► Subscribe
Cipher Pharms Inc
LIPOFEN
fenofibrate
CAPSULE;ORAL021612-001Jan 11, 2006RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Cipher Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cipher Pharms Inc
LIPOFEN
fenofibrate
CAPSULE;ORAL021612-001Jan 11, 2006► Subscribe► Subscribe
Cipher Pharms Inc
LIPOFEN
fenofibrate
CAPSULE;ORAL021612-003Jan 11, 2006► Subscribe► Subscribe
Cipher Pharms Inc
LIPOFEN
fenofibrate
CAPSULE;ORAL021612-002Jan 11, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Cipher Pharms Inc Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2004110410► Subscribe
Canada2495463► Subscribe
Australia2002337967► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Cipher Pharms Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00152Netherlands► SubscribePRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
C/GB04/012United Kingdom► SubscribePRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Healthtrust
Julphar
Chinese Patent Office
McKinsey
Fuji
AstraZeneca
Colorcon
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot